Argent BioPharma Limited
RGT.L · LSE
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £0 | £0 | £0 | £0 |
| Dep. & Amort. | £0 | £0 | £0 | £0 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | £0 | £0 | £0 | £0 |
| Other Non-Cash | -£7,737 | £0 | £0 | £0 |
| Operating Cash Flow | -£7,737 | £0 | £0 | £0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£140 | -£190 | -£2,693 | -£3,327 |
| Net Acquisitions | £0 | £0 | -£5 | -£373 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £303 |
| Other Inv. Act. | £0 | £796 | £1,586 | £1,904 |
| Investing Cash Flow | -£140 | £606 | -£1,111 | -£1,494 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £7,164 | £61 | £5,750 |
| Stock Issued | £15,701 | £3,087 | £10,703 | £12,760 |
| Stock Repurch. | £0 | -£318 | -£764 | -£1,203 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£7,049 | -£201 | -£263 | -£256 |
| Financing Cash Flow | £8,055 | £9,732 | £9,738 | £17,051 |
| Forex Effect | -£1 | £9 | -£15 | -£8 |
| Net Chg. in Cash | £463 | -£1,647 | -£3,547 | £3,560 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £240 | £1,886 | £5,433 | £1,873 |
| End Cash | £703 | £240 | £1,886 | £5,433 |
| Free Cash Flow | -£14,402 | -£12,185 | -£14,851 | -£15,317 |